The Pharma Navigator
@thepharmanavigator.bsky.social
Navigating the key news stories in pharma.
https://www.thepharmanavigator.com/
https://www.thepharmanavigator.com/
A major new review, published in The Lancet Obstetrics, Gynaecology, & Women’s Health, has effectively disproved claims that taking acetaminophen/paracetamol during pregnancy causes autism, ADHD, or intellectual disability in children.
Read here👇
Read here👇
Systematic Review Shows No Evidence of Link Between Acetaminophen and Autism — The Pharma Navigator - Navigating The Key News Stories In Pharma
Claims that the use of acetaminophen/paracetamol while pregnant is linked to autism have been effectively disproved through a rigorous review and meta-analysis of current evidence.
www.thepharmanavigator.com
January 28, 2026 at 2:09 PM
A major new review, published in The Lancet Obstetrics, Gynaecology, & Women’s Health, has effectively disproved claims that taking acetaminophen/paracetamol during pregnancy causes autism, ADHD, or intellectual disability in children.
Read here👇
Read here👇
Vetter Pharma has advanced its next‑generation tamper‑evident syringe closure from design finalization to industrialization ahead of a planned 2027 launch to strengthen its position in prefilled drug‑delivery solutions.
Read the article here👇
Read the article here👇
Vetter Advances Next-Generation Tamper-Evident Syringe Closure Towards Launch — The Pharma Navigator - Navigating The Key News Stories In Pharma
The company has advanced its next‑generation tamper‑evident syringe closure from design finalization to industrialization ahead of a planned 2027 launch to strengthen its position in prefilled drug‑delivery...
www.thepharmanavigator.com
January 27, 2026 at 2:30 PM
Vetter Pharma has advanced its next‑generation tamper‑evident syringe closure from design finalization to industrialization ahead of a planned 2027 launch to strengthen its position in prefilled drug‑delivery solutions.
Read the article here👇
Read the article here👇
In our latest interview, Will Downie (Downie Pharma Advisory) and John Cogan (Qinecsa) unpack how the industry is weathering geopolitical uncertainty, regulatory shifts, and inflationary pressures with fresh optimism and renewed focus.
Listen here👇
www.thepharmanavigator.com/news/weather...
Listen here👇
www.thepharmanavigator.com/news/weather...
Weathering Headwinds: Bio/Pharma’s Roadmap for Success in 2026 — The Pharma Navigator - Navigating The Key News Stories In Pharma
Despite geopolitical uncertainties, regulatory reforms, and fluctuating capital expenditure, the bio/pharma industry is entering 2026 with renewed focus and confidence.
www.thepharmanavigator.com
January 26, 2026 at 3:50 PM
In our latest interview, Will Downie (Downie Pharma Advisory) and John Cogan (Qinecsa) unpack how the industry is weathering geopolitical uncertainty, regulatory shifts, and inflationary pressures with fresh optimism and renewed focus.
Listen here👇
www.thepharmanavigator.com/news/weather...
Listen here👇
www.thepharmanavigator.com/news/weather...